NCT07535307RecruitingPhase 1
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes
Source: EU CTIS (euclinicaltrials.eu) · Last updated 20 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 9 Jan 2026
- Start date
- 25 Mar 2026
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Type 2 diabetes
- EU CT number
- 2025-521595-55-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 80
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PROFIL Institut fuer Stoffwechselforschung GmbH Coordinator of this site? Confirm its status | Neuss | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.